Miroculus Stock

Miroculus is a hands off sample-to-answer solution for molecular testing.

About Miroculus Stock

Miroculus is a hands off sample-to-answer solution for molecular testing. Miroculus delivers assay flexibility and automation capacity in an affordable digital microfluidics platform, which enables seamless workflow integration from novel molecular protocols to data analytics.

Funding History

January 2014	$0
September 2014	$500K
April 2015	$2.3M
May 2016	$50K
October 2016	$0
August 2018	$17.2M

Management

CTO

Jorge Soto

Chief Scientific Officer

Foteini Christodoulou

CEO

Alejandro Tocigl

Other Companies

Learn More

BillionToOne

BillionToOne is a precision diagnostics company that makes molecular diagnostics accurate, efficient, and accessible for all.

Health Scholars is transforming the way clinical education and training are delivered.

A platform for collaborative data analytics

Metabolon develops analytical methods and software for biomarker discovery by using metabolomics.

It’s time to reimagine what’s possible in healthcare.

2Age (years)

$69.0MTotal Funding

EquityZen does not have an affiliation with, formal relationship with, or endorsement from any companies featured above. This profile is based on publicly available information and is intended to be informative in nature.

Some data provided by Crunchbase

Trending Companies

Join 280K+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As:

Why EquityZen?

EquityZen helps investors to access private companies and their employees to sell shares.

Request Access

Investment opportunities posted on this website are "private placements" of securities that are not publicly traded, are subject to holding period requirements, and are intended for investors who do not need a liquid investment. Investing in private companies may be considered highly speculative and involves a high degree of risk, including the risk of substantial loss of investment. Investors must be able to afford the loss of their entire investment. See our Risk Factors for a more detailed explanation of the risks involved by investing through EquityZen’s platform.

EquityZen Securities LLC (“EquityZen Securities”) is a subsidiary of EquityZen Inc. EquityZen Securities is a broker/dealer registered with the Securities Exchange Commission and is a FINRA/SIPC member firm.

Equity securities are offered through EquityZen Securities. Check the background of this firm on FINRA’s BrokerCheck.

EquityZen.com is a website operated by EquityZen Inc. ("EquityZen"). By accessing this site and any pages thereof, you agree to be bound by our Terms of Use.
EquityZen and logo are trademarks of EquityZen Inc. Other trademarks are property of their respective owners.
© 2022 EquityZen Inc. All rights reserved.